Beetham Thomas W. Insider Trades

Insider Trading History

Track insider trading activity for Beetham Thomas W.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Operating Officer
Holding Value $231k 13,361 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$92k 3,048 shares
$30.19
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Operating Officer
Holding Value $488k 28,227 shares
Last Trade
Mar 03, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$276k 9,409 shares
$29.32
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Operating Officer
Holding Value $284k 16,409 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$276k 9,409 shares
$29.32
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Operating Officer
Holding Value $229k 13,271 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$92k 3,138 shares
$29.32
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Operating Officer
Holding Value $3.05M 176,550 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.41M 211,850 shares
$30.25
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Operating Officer
Holding Value $3.9M 225,814 shares
Last Trade
Mar 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.25M 225,814 shares
$14.41
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Operating Officer
Holding Value $104k 6,000 shares
Last Trade
Sep 27, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$117k 5,000 shares
$23.41
$17.28
Viridian Therapeutics
Viridian Therapeutics VRDN
Chief Operating Officer
Holding Value $8.2M 474,400 shares
Last Trade
Oct 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.18M 474,400 shares
$13.02
$17.28
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $13.9k 19,897 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.45k 3,000 shares
$1.15
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Title: Chief Legal Officer And Secretary
Holding Value $1.74M 19,897 shares
Last Trade
Nov 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.45k 3,000 shares
$1.15
$87.53
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $52.5k 75,000 shares
Last Trade
Aug 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 75,000 shares
$1.57
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Title: Chief Legal Officer And Secretary
Holding Value $6.56M 75,000 shares
Last Trade
Aug 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 75,000 shares
$1.57
$87.53
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $11.8k 16,897 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.48k 3,000 shares
$1.16
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Title: Chief Legal Officer And Secretary
Holding Value $1.48M 16,897 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.48k 3,000 shares
$1.16
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Title: Chief Legal Officer And Secretary
Holding Value $4.38M 50,000 shares
Last Trade
May 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59k 50,000 shares
$1.18
$87.53
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $35k 50,000 shares
Last Trade
May 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59k 50,000 shares
$1.18
$0.70
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $52.5k 75,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 75,000 shares
$3.19
$0.70
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $9.72k 13,897 shares
Last Trade
Sep 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$41.1k 6,103 shares
$6.73
$0.70
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $14k 20,000 shares
Last Trade
Sep 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$123k 20,000 shares
$6.13
$0.70
Magenta Therapeutics
Magenta Therapeutics MGTA
See Remarks
Holding Value $140k 200,000 shares
Last Trade
Jun 14, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.27M 200,000 shares
$11.37
$0.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up